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In this special issue of Journal of Lipids, we acknowledge the
c o n t r i b u t i o n sb ys e v e r a le x p e r t so ﬀering timely perspectives
on the complex interactions between bile acids and nuclear
receptors (NRs) on lipid metabolism and liver diseases at
diﬀerent levels and contexts in the body.
NRs are found within the interior of cells and are deﬁned
as ligand-activated transcriptional regulators of several key
aspects of body physiology and pathophysiology. NRs regu-
late gene transcription through interaction with cellular
coactivatorsandcorepressors.Intheliver,NRsplayakeyrole
in a large variety of metabolic processes such as cholesterol,
bile acid, fatty acid, and glucose homeostasis, as well as drug
disposition. Also, additional critical processes involving the
pathophysiology of liver diseases—inﬂammation and ﬁbro-
sis,regeneration,celldiﬀerentiation,andtumorformation—
are modulated by NRs. Of note, NRs are or might soon be-
come drug targets. Despite the huge accumulation of knowl-
edge in the ﬁeld, the true comprehension of interactions
between bile acids and NRs on lipid metabolism and hepato-
biliarydiseaseshasremainedelusive.Thuscontinuouseﬀorts
are being made to understand the molecular functions of
NRs, the signiﬁcance of bile acid-controlled signaling path-
ways, and interactions of NRs on a number of metabolic and
hepatic diseases.
The paper of T. Li and Y. L. Chiang is focused on the role
of bile acid signaling in the regulation of glucose and
lipid metabolism. Besides their detergent properties and key
physiological functions, bile acids are also acting as potent
metabolic regulators of glucose and lipid homeostasis. The
identiﬁcation of bile acid-activated nuclear receptor farne-
soid X receptor (FXR) and cell surface G-protein-coupled
receptor TGR5 has signiﬁcantly advanced our understanding
on how bile acid signaling regulates cellular metabolism in
health and disease. Thus, novel therapeutic strategies can be
envisioned which target bile acid metabolism for the treat-
ment of metabolic disorders such as obesity, insulin resist-
ance, and the metabolic syndrome.
NRs comprise one of the most abundant classes of tran-
scriptional regulators of metabolic diseases and have
emerged as promising pharmaceutical targets. The paper by
G. Garruti et al. deals with the myriad roles of small het-
erodimer partner (SHP), a unique orphan nuclear receptor
lacking a DNA-binding domain, but containing a putative
ligand-binding domain. About half of mammalian NRs and
several transcriptional coregulators can interact with SHP.
SHP is a transcriptional regulator aﬀecting multiple key bi-
ological functions and metabolic processes including choles-
terol, bile acid, and fatty acid metabolism, as well as repro-
ductive biology and glucose-energy homeostasis. In humans,
studies are emerging on the association of SHP genetic
variation with birth weight, high body mass index, obesity,
insulin resistance, and diabetes. Future research must be2 Journal of Lipids
focused on synthetic ligands acting on SHP as a potential
therapeutic target in a series of metabolic abnormalities.
One important issue in lipidology is the understanding
of the molecular mechanisms whereby cholesterol and fatty
acids are absorbed from the intestine and are transported
to the liver. The cholesterol absorption inhibitor ezetimibe
can signiﬁcantly reduce plasma total and LDL cholesterol
concentrations by inhibiting the Niemann-Pick C1-like 1
protein(NPC1L1),anintestinal sterolinﬂuxtransporterthat
can actively facilitate the uptake of cholesterol for intestinal
absorption. The paper by O. de Bari et al. emphasizes the
novel concept that, ezetimibe treatment also induces a com-
plete resistance to two frequent metabolic abnormalities,
namely, cholesterol gallstones and nonalcoholic fatty liver
disease (NAFLD). Furthermore, it prevented hypercholes-
terolemia in mice on a Western diet. This model has high
translational value and points to a key role for chylomicrons,
the natural lipid carriers used by enterocytes to transport
cholesterol and fatty acids into the body. The hypothesis that
ezetimibe could prevent two prevalent hepatobiliary diseases
(i.e., cholesterol cholelithiasis and liver steatosis) possibly
through the regulation of chylomicron-derived cholesterol
and fatty acid metabolism in the liver is discussed here.
Because several proteins are implicated in determining
biliary lipid secretion in the liver and are regulated by several
transcription factors, including nuclear receptors liver X
receptor (LXR) and FXR, the paper by M. C. V´ azquez et al.
is focused on molecular mechanisms underlying the link
between nuclear receptor function and the formation of
cholesterol gallstones. A potent role for estrogen receptors
in the pathogenesis of cholesterol gallstone disease, involving
both genomic and nongenomic activation of signaling path-
ways,isdiscussed.Evidenceinthisrespectisheavilysupport-
ed by human and murine genetic, physiological, pathophysi-
ological,andpharmacologicalstudies.Indeed,expandingthe
knowledge about the role of NRs in gallstone formation will
certainly lead to the discovery of novel and more eﬀective
therapeutic strategies in a typical example of a metabolic
“mass disease,” that is, cholesterol cholelithiasis.
In the wide ﬁeld of lipopathy, NAFLD is currently evolv-
ing as the most common liver disease worldwide, with po-
tential costly and severe sequelae, including liver cirrhosis
and hepatocellular carcinoma. In his paper, M. Fuchs under-
scored the concept that NAFLD not only represents an insu-
lin resistance state characterized by a cluster of dysmetabolic
cardiovascular risk factors, but also represents an indepen-
dent risk factor for cardiovascular diseases. Of note, the bile
acid-activated nuclear receptor FXR has been shown to play
a role not only in bile acid but also in lipid (cholesterol and
triglyceride) metabolism and glucose homeostasis. Speciﬁc
targeting of FXR may be an elegant and very eﬀective way to
readjust dysregulated nuclear receptor-mediated metabolic
pathways.ActivationofFXRmayresultinnot onlybeneﬁcial
actions but also potential undesirable side eﬀects. One
exampleisthe(stillunpredictable)balancebetweenpro-and
anti-atherogenic eﬀects of FXR activation.
J. A. L´ opez-Vel´ azquez et al. described the important role
of several NRs in the liver as regulators of several critical
metabolicstepsinvolvedinthepathogenesisofNAFLD.Such
crucial steps include fat storage, export, uptake, oxidation,
and lipolysis. A whole family of NRs is targeted by many
ligands controlling lipid metabolism including fatty acids,
oxysterols, and lipophilic molecules. Understanding the
molecular mechanisms underlying the involvement of NRs
in the pathogenesis of NAFLD may, therefore, oﬀer targets
for the development of new treatments of one of the most
frequent chronic liver diseases worldwide.
In their paper, R. M¨ ullenbach et al. provided an update
on genetic variants of NRs involved in regulating important
aspects of liver metabolism. One such aspect is the applica-
tion of NRs in genetic diagnosis of monogenic (Mendelian)
liver diseases and their uses in clinical diagnosis. Moreover,
a role of NR polymorphisms in common diseases can be
anticipated, linking regulatory networks to complex and var-
iable phenotypes. Technical advances contribute to the rest-
less expansion of knowledge and include transgenic animal
models, expression quantitative trait loci (eQTL) mapping,
and genomewide association studies (GWASs). Thus, it is
highly likely that personal genome information might even-
tually be able to predict a variety of risks associated with an
individual’s lifestyle such as high fat diet and alcohol as well
as susceptibility to infectious liver diseases such as hepatitis
Bo rC .
Menopause is a consequence of the normal aging process
inwomenanditisthoughtthatmenopauseisassociatedwith
a higher risk for cardiovascular diseases. Indeed, the post-
menopause lipid proﬁle is often altered, which represents
a risk factor for cardiovascular diseases. The paper by P. J.
Oliveira et al. reports on the mechanisms linking alterations
ofmitochondrialbioenergeticsintheheart,asaconsequence
from normal aging and/or from the menopausal process,
to decreased fatty acid oxidation and accumulation of fatty
acid intermediates in the cardiomyocyte cytosol. Such lipo-
toxic consequences might represent the important link to
increased cardiovascular risk in the menopausal women.
In conclusion, the ﬁeld of lipidology has become even
more complex and exciting when considering that the dis-
covery of NRs and their pleiotropic functions have opened
the way to multidimensional, multidisciplinary and transla-
tional studies. Since NRs are involved in virtually all physio-
logical functions, understanding how NRs work is therefore
essential to explain the complex pathophysiological mecha-
nisms underlying liver and extrahepatic diseases. A new era
in which NRs will represent valid therapeutic targets for
several disorders is hopefully approaching.
Lastly, we hope that this contribution will also help both
young and experienced investigators in their daily diﬃcult
task to expand their research in the ﬁeld of experimental and
clinical lipidology in health and disease.
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